Allergan Aesthetics’ US$550 Million Acquisition Of Soliton and RESONIC

Hogan Lovells advised Soliton on the deal.Allergan Aesthetics, an AbbVie company, will acquire Soliton and RESONIC, its Rapid Acoustic Pulse device, for approximately US$550 million. RESONIC,…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now